PLOD1 and Insulin resistance: Primary outcomes included changes in hormonal markers (e.g., estrogen, progesterone, LH/FSH ratio, testosterone), symptom scores for PMS, and metabolic parameters (e.g., BMI, lipid profile, insulin resistance).